Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2016 3
2017 1
2018 6
2019 3
2020 7
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.
Leaf RK, Ferreri C, Rangachari D, Mier J, Witteles W, Ansstas G, Anagnostou T, Zubiri L, Piotrowska Z, Oo TH, Iberri D, Yarchoan M, Salama AKS, Johnson DB, Leavitt AD, Rahma OE, Reynolds KL, Leaf DE. Leaf RK, et al. Among authors: ansstas g. Am J Hematol. 2019 May;94(5):563-574. doi: 10.1002/ajh.25448. Epub 2019 Mar 13. Am J Hematol. 2019. PMID: 30790338 Free article. Clinical Trial.
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.
Johanns TM, Miller CA, Dorward IG, Tsien C, Chang E, Perry A, Uppaluri R, Ferguson C, Schmidt RE, Dahiya S, Ansstas G, Mardis ER, Dunn GP. Johanns TM, et al. Among authors: ansstas g. Cancer Discov. 2016 Nov;6(11):1230-1236. doi: 10.1158/2159-8290.CD-16-0575. Epub 2016 Sep 28. Cancer Discov. 2016. PMID: 27683556 Free PMC article.
Mutation clearance and complete radiologic resolution of immunotherapy relapsed metastatic melanoma after treatment with nivolumab and olaparib in a patient with homologous recombinant deficiency: any role for PARP inhibitors and checkpoint blockade?
Khaddour K, Ansstas M, Visconti J, Ansstas G. Khaddour K, et al. Among authors: ansstas g. Ann Oncol. 2021 Feb;32(2):279-280. doi: 10.1016/j.annonc.2020.10.602. Epub 2020 Dec 9. Ann Oncol. 2021. PMID: 33308899 No abstract available.
Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation.
Khaddour K, Dowling J, Huang J, Council M, Chen D, Cornelius L, Johanns T, Dahiya S, Ansstas G. Khaddour K, et al. Among authors: ansstas g. Oncotarget. 2020 Dec 29;11(52):4836-4844. doi: 10.18632/oncotarget.27848. eCollection 2020 Dec 29. Oncotarget. 2020. PMID: 33447351 Free PMC article.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page